Economic evaluation of delivering Haemophilus influenzae type b vaccine in routine immunization services in Kenya
Angela Oloo Akumu, Mike English, J Anthony G Scott, Ulla K Griffiths
Volume 85, Number 7, July 2007, 511-518
Table 3. Estimated annual cost (US$) of vaccines and injection equipment in Kenyan public health sector with and without the pentavalent vaccine (2004)
| Antigen | Doseper vial | Wastage (%) | Costs per dose (including freight) | No. of children reached | Total vaccine costs | Injection supply costsa | Total | % of total |
|---|---|---|---|---|---|---|---|---|
| Bacille Calmette–Guérin | 20 | 70 | 0.10 | 1 150 140 | 372 645 | 86 133 | 458 778 | 3.2% |
| DTP+hep B+Hib (pentavalent) | 2 | 15 | 3.70 | 965 060 | 12 618 727 | 305 519 | 12 924 246 | 89.6% |
| Measles | 10 | 65 | 0.17 | 900 820 | 150 329 | 70 815 | 221 144 | 1.5% |
| Oral polio vaccine | 20 | 10 | 0.11 | 965 060 | 468 118 | – | 468 118 | 3.2% |
| Tetanus toxoid | 20 | 15 | 0.03 | 926 914 | 179 603 | 137 831 | 317 434 | 2.2% |
| Yellow fever | 10 | 65 | 0.82 | 15 871 | 37 366 | 1 248 | 38 614 | 0.3% |
| – | – | – | – | |||||
| DTP+hep B combination vaccine | 10 | 35 | 1.23 | 965 060 | 5 497 279 | 210 468 | 5 707 747 | – |
| – | – | – | – | – | ||||
| Incremental costs of pentavalent vaccine compared with DTP+hep B | – | – | – | – | 7 121 448 | 95 050 | 7 216 499 | – |
DTP, diphtheria-tetanus-pertussis; hep B, hepatitis B; Hib, Haemophilus influenzae type b.a Injection supply costs consist of auto-disable syringes, reconstitution syringes and safety boxes.